Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 18;12(4):613.
doi: 10.3390/pathogens12040613.

Reduced Cholesterol Levels during Acute Human Babesiosis

Affiliations

Reduced Cholesterol Levels during Acute Human Babesiosis

Luis A Marcos et al. Pathogens. .

Abstract

Background: Babesiosis, an intra-erythrocytic protozoan disease, is an emerging zoonotic parasitic disease worldwide. Cholesterol levels are correlated with severe infections, such as sepsis and COVID-19, and anecdotal reports suggest that high-density lipoprotein (HDL) cholesterol declines during acute babesiosis. Our aim was to describe the cholesterol levels in patients with acute babesiosis diagnosed in an endemic area in New York, hypothesizing that HDL levels correlate with the severity of infection.

Methods: We reviewed the medical records of adult patients with babesiosis diagnosed by identification of Babesia parasites on a thin blood smear and confirmed by polymerase chain reaction from 2013 to 2018, who also had available a lipid profile drawn at the time of clinical presentation. Additional lipid profile levels were considered as "baseline" if they were drawn within 2 months before or after the infection as part of routine care.

Results: A total of 39 patients with babesiosis had a lipid profile drawn on presentation. The patients were divided into two groups for comparison based on the treating physician's clinical decision: 33 patients who were admitted to the hospital and 8 patients who were evaluated as outpatients. A history of hypertension was more common in admitted patients (37% vs. 17%, p = 0.02). The median levels of low-density lipoprotein (LDL) and HDL were significantly reduced in admitted patients compared to non-admitted patients (46 vs. 76 mg/dL, p = 0.04; and 9 vs. 28.5 mg/dL, p = 0.03, respectively). In addition, LDL and HDL levels returned to baseline values following resolution of acute babesiosis.

Conclusion: LDL and HDL levels are significantly reduced during acute babesiosis, suggesting that cholesterol depletion may predict disease severity. Pathogen and host factors may contribute to a reduction in serum cholesterol levels during acute babesiosis.

Keywords: Babesia; cholesterol; high-density lipoprotein; lipids; low-density lipoprotein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
HDL levels in acute babesiosis (x axis: left of zero = days prior to diagnosis of acute babesiosis; right of zero = levels drawn post-acute infection; zero = day 0 of acute infection; y axis: level of HDL in mg/dL). Blue dots represent patients who were not admitted to hospital. Red dots represent patients who were admitted. Note: HDL levels markedly decreased during acute infection, returning to baseline levels after infection during follow up.

References

    1. Kumar A., O’Bryan J., Krause P.J. The Global Emergence of Human Babesiosis. Pathogens. 2021;10:1447. doi: 10.3390/pathogens10111447. - DOI - PMC - PubMed
    1. Kletsova E.A., Spitzer E.D., Fries B.C., Marcos L.A. Babesiosis in Long Island: Review of 62 cases focusing on treatment with azithromycin and atovaquone. Ann. Clin. Microbiol. Antimicrob. 2017;16:26. doi: 10.1186/s12941-017-0198-9. - DOI - PMC - PubMed
    1. Puri A., Bajpai S., Meredith S., Aravind L., Krause P.J., Kumar S. Babesia microti: Pathogen Genomics, Genetic Variability, Immunodominant Antigens, and Pathogenesis. Front. Microbiol. 2021;12:697669. doi: 10.3389/fmicb.2021.697669. - DOI - PMC - PubMed
    1. Marcos L.A., Leung A., Kirkman L., Wormser G.P. Use of tafenoquine to treat a patient with relapsing babesiosis with clinical and molecular evidence of resistance to azithromycin and atovaquone. IDCases. 2022;27:e01460. doi: 10.1016/j.idcr.2022.e01460. - DOI - PMC - PubMed
    1. Zahra A., Marcos L.A. Hemagophagocytic lymphohistiocytosis associated with recurrent Babesiosis with Lyme disease co-infection in an immunocompromised host on anti-CD20 monoclonal antibody therapy: A case report. IDCases. 2022;29:e01570. doi: 10.1016/j.idcr.2022.e01570. - DOI - PMC - PubMed

LinkOut - more resources